Found 19 matching trials
5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:
NAStereotactic Ablative Body Radiotherapy (SABR) given in 5 weekly fractions....
Location
Sunnybrook Health Sciences Center
Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer
PHASE2The hypo-FLAME study is a multicenter phase II study (n=100) to investigate...
ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0
N/APublished clinical evidence confirms that a single dose of 24 Gy provides u...
Location
Radiation Oncology, Fondazione IRCCS San Gerardo dei Tintori
PSMA PET Response Guided SabR in High Risk Pca
PHASE1Sequential cohort evaluation of ideal timing of imaging and treatment spaci...
Location
University of Texas Southwestern Medical Center
Targeted Radiotherapy for Recurrent Prostate Cancer
NAThe TASTEPRO pilot trial evaluates the feasibility of PSMA PET-CT (Computer...
Location
Tampere University Hospital
PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer
PHASE2PRO-BOOST-N is a prospective, multicenter, randomized phase II/III clinical...
Location
Affidea Nu-Med, Center of Oncological Diagnostics and Therapy
Stereotactic Pelvic Brachytherapy With HDR Boost for Dose Escalation in High Tier Intermediate and High Risk Prostate ca
NAHDR brachytherapy in conjunction with pelvic SABR in high tier intermediate...
Location
Sunnybrook Health Sciences Center
SBRT Boost for Unfavorable Prostate Cancer'
NAThe purpose of this study is to find out whether giving a short course of f...
Location
Orange Coast Memorial Medical Center
Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0
PHASE2The hypo-FLAME 2.0 study is a multicenter phase II study (n=124) investigat...
Status
Active Not Recruiting
Location
University Hospitals Leuven
SBRT With Focal Dose Escalation on DIL in Localized Prostate Cancer
NAStereotactic ablative Body Radiotherapy (SBRT) is an advanced radiation tec...
Location
La Princesa University Hospital, Health Research Institute, Madrid